SCHEMBL8134192

SCHEMBL8134192

CCCC(=O)c1cc[c]c(OC)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B3 P37058 1/20 0.43
HPGD P15428 6/20 0.42
PDE4D Q08499 5/20 0.41
PDE4A P27815 4/20 0.41
PDE4B Q07343 4/20 0.41
PDE4C Q08493 4/20 0.41
SMN1; SMN2 Q16637 2/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
CTNNB1 P35222 2/20 0.39
WNT3A P56704 2/20 0.39
STS P08842 1/20 0.39
HDAC3 O15379 1/20 0.38
HDAC4 P56524 1/20 0.38
HDAC1 Q13547 1/20 0.38
HDAC7 Q8WUI4 1/20 0.38
HDAC2 Q92769 1/20 0.38
HDAC10 Q969S8 1/20 0.38
HDAC11 Q96DB2 1/20 0.38
HDAC8 Q9BY41 1/20 0.38
HDAC6 Q9UBN7 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3830003 0.87 KMT2A (0.44) HPGDSMN1; SMN2L3MBTL1ALDH1A1CYP1A2
SCHEMBL8121019 0.79 ALDH1A1 (0.42) HPGDPDE4DPDE4APDE4BPDE4C
SCHEMBL9676481 0.79 CYP1A2 (0.47) HPGDL3MBTL1ALDH1A1CYP1A2CYP2C19
SCHEMBL11331870 0.78 KDM4E (0.55) HPGDSMN1; SMN2STSHDAC6ALDH1A1
SCHEMBL221066 0.78 ALDH1A1 (0.42) HPGDSMN1; SMN2L3MBTL1ALDH1A1MAPT
SCHEMBL2422430 0.78 TPMT (0.48) RAB9ANPC1
SCHEMBL4775443 0.77 HSD17B2 (0.53) SMN1; SMN2ALDH1A1CYP1A2CYP2C19KMT2A
SCHEMBL3883974 0.77 HSD17B3 (0.46) HSD17B3HPGDPDE4DPDE4APDE4B
SCHEMBL26688583 0.76 SMN1; SMN2 (0.43) HPGDSMN1; SMN2L3MBTL1ALDH1A1MAPT
SCHEMBL358188 0.76 PARP1 (0.49)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0763524-B1 Urea and amide derivatives having ACAT inhibitory activity, their preparation and their therapeutic and prophylactic use SANKYO CO (JP) 2000-08-23 EP disclosed
US-6040339-A TREATMENT AND PROPHYLAXIS OF HYPERCHOLESTEREMIA OR ARTERIOSCLEROSIS IN A MAMMAL SANKYO COMPANY, LIMITED (JP) 2000-03-21 US disclosed
US-5880147-A Amide derivatives having ACAT inhibitory activity, their preparation and their therapeutic and prohylactic use SANKYO COMPANY, LIMITED (JP) 1999-03-09 US disclosed
EP-0763524-A1 Urea and amide derivatives having ACAT inhibitory activity, their preparation and their therapeutic and prophylactic use SANKYO COMPANY LIMITED (JP) 1997-03-19 EP disclosed